Vaxcyte Inc at Bank of America Healthcare Conference Transcript
All right, everybody. Thanks for joining us for our next company presenter at the Bank of America Annual Healthcare Conference in Las Vegas. My name is Jason Gerberry, I'm one of the biotech analyst at BofA, and I'm pleased to be introducing our next company presenter, Vaxcyte. We've got Grant Pickering, CEO; and we've got Jim Wassil, COO, with us on stage. Gentlemen, both, thanks for joining us.
Thank you for having us.
So maybe, I don't know, Grant, if you want to set the stage at all for Vaxcyte. Who you guys are as a company. Set the stage in terms of pneumococcal vaccination as a marketplace. I don't think that it needs a lot of context. It's a very large market at $7 billion global revenue, and forecasted to go, I think, upwards of like $8 billion to $10 billion in the future
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
